Quality Means Business

United States - Boston, Massachusetts

• 13/11/2025
• Seed
• $2,000,000

Quality Means Business (QMB, Inc.) is redefining how MedTech leaders build trust, scale globally, and deliver life-changing innovation.

We’ve built MedTech’s first Intelligent Engine to democratize and de-risk regulatory compliance and new product development (NPD), while accelerating time-to-market. This engine doesn’t just track — it thinks: generating FDA-ready documentation, guiding regulatory strategy, and benchmarking critical decisions against global standards and requirements in real time.

Our flagship platform, QualiVerse®, is a vertical SaaS solution — purpose-built by regulatory pros, for regulatory pros — turning compliance into a competitive advantage. Most legacy enterprise tools offer systems of recording; we deliver a platform of assisted intelligence that evolves with every product decision.

We elevate Quality and Regulatory leaders from gatekeepers to growth architects, empowering them to drive faster approvals, safer operations, and lead with smart confidence.

In an industry where trust, safety, and speed define the winners, we give MedTech companies an AI-native, cloud workspace to move like Fortune 100 giants — with the agility of a startup and the precision of a market leader.

Related People

Michel E. Moravia, MBA, MSEFounder

United States - Greater Boston

I founded QMB Inc. with one conviction: that regulatory strategy should never be the barrier keeping life-saving medical technologies from reaching patients. For years, we partnered with MedTech and biopharma leaders navigating the unforgiving landscape of FDA submissions, denials, and compliance risk. From that front-line experience, one truth became clear—traditional consulting could only scale so far. The future required a platform.

That insight gave birth to QualiVerse, QMB’s flagship SaaS product and the first AI-native platform built by regulatory professionals for regulatory professionals. QualiVerse leverages a proprietary regulatory knowledge graph, AI agents, and a patent-pending algorithm to reimagine the submission process. The result? Faster clearances, fewer denials, and stronger compliance postures—transforming regulatory from a bottleneck into a competitive advantage.

I thrive at the intersection of regulatory intelligence, AI innovation, and venture-scale growth. My mission is to ensure the next generation of healthcare breakthroughs reach patients without being slowed, or stopped, by outdated systems.

LinkedIn https://www.linkedin.com/in/moraviameansquality/